ClinConnect ClinConnect Logo
Search / Trial NCT01423162

Iron Bioavailability of Fortified Oat Drink

Launched by PEPSICO GLOBAL R&D · Aug 24, 2011

Trial Information

Current as of May 01, 2025

Completed

Keywords

Iron Absorption Oats Fortified Oat Beverages

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 6 year old children (inclusive)
  • Normal BMI for age (WHO standard: 15.3-15.5 kg)
  • Apparently healthy, no metabolic or gastrointestinal disorder; non-anemic (Hemoglobin values not less than 11.5 mg/dL -WHO cut-off for respective age)
  • No medication or vitamin/mineral supplement will be consumed during the study; intake of vitamin/mineral supplement will be discontinued 2 weeks before the start of the study
  • Parents demonstrate an understanding of the given information and ability to comply with the study procedure
  • Obtained parental or legal representative's informed consent
  • Exclusion Criteria:
  • Known gastrointestinal or metabolic disorder or experiencing blood losses over the past 6 months;
  • Children taking medication
  • Children who are anemic (Hemoglobin values less than 11.5 mg/dL - WHO cut-off value for this age)
  • Currently participating or having participated in another clinical trial during the past 3 months prior to the beginning of the study

About Pepsico Global R&D

PepsiCo Global R&D is a leading innovator in the food and beverage industry, dedicated to advancing the science of nutrition and product development. With a strong focus on health and wellness, the organization conducts rigorous clinical trials to explore the efficacy and safety of its products, aiming to enhance consumer experiences while promoting sustainable practices. Leveraging cutting-edge research methodologies and a multidisciplinary approach, PepsiCo Global R&D collaborates with academic institutions and healthcare professionals to drive evidence-based advancements in nutrition, ensuring that its offerings meet the evolving needs of consumers worldwide.

Locations

Taguig City, , Philippines

Patients applied

0 patients applied

Trial Officials

Trinidad P Trinidad, PhD

Principal Investigator

FNRI

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials